Anaemia in inflammatory bowel disease

Area of Science:

• Gastroenterology
• Hematology
• Internal Medicine

Background:

• Anemia is a frequent complication of inflammatory bowel disease (IBD), significantly reducing patient quality of life.
• Common causes include iron deficiency and anemia of chronic disease.
• Oral iron therapy for iron deficiency anemia in IBD can cause gastrointestinal intolerance.

Purpose of the Study:

• To review the current understanding and recent advancements in managing anemia in IBD patients.
• To highlight the efficacy and safety of novel intravenous iron formulations.

Main Methods:

• Literature review of recent studies and clinical trials.
• Analysis of treatment outcomes for oral versus intravenous iron therapy in IBD.

Main Results:

• Intravenous iron formulations offer a safe, rapid, and effective method for correcting iron deficiency in IBD.
• These newer formulations may circumvent the gastrointestinal side effects associated with oral iron.

Conclusions:

• Intravenous iron therapy represents a significant advancement in managing anemia in IBD.
• Gastroenterologists should consider these options for effective patient treatment and improved outcomes.